Latest News

Date Title Topic
09 May 2014 IMPAKT 2014 News: Adoption of Multi-gene Assays in Hormone Receptor-Positive, HER2-Negative Breast Cancer Breast cancer - Personalised medicine
09 May 2014 IMPAKT 2014 News: Therapeutic Effect and Markers of Response of Palbociclib in HER2-Positive Breast Cancer Models Breast cancer - Translational research - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Enzalutamide With or Without an Aromatase Inhibitor for Advanced Breast Cancer Breast cancer - Translational research
07 May 2014 Molecular Tumour Board Helps in Advanced Cancer Cases Personalised medicine
06 May 2014 ESMO E-Learning: New platform
06 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Denosumab Genitourinary cancers - Palliative and supportive care
05 May 2014 Withdrawal of Application for EMA Change to the Marketing Authorisation of Pazopanib Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Two HPV Vaccines Cancer prevention - Gynaecologic malignancies - Gastrointestinal cancers
07 Jul 2014 Updated 2014 ESMO Clinical Practice Guidelines
30 Apr 2014 ESMO E-Learning: Future Directions in Clinical Research of NSCLC
30 Apr 2014 The Role of Postoperative Radiation Therapy for Endometrial Cancer Gynaecologic malignancies
29 Apr 2014 EMA Recommends Granting a Marketing Authorisation for Trametinib and Extending Indications for Sorafenib Melanoma - Endocrine cancers - Anticancer agents & Biologic therapy
28 Apr 2014 ESMO V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma
28 Apr 2014 EORTC and SIOG Update Expert Opinion on Management of Elderly Patients with NSCLC Cancer in Special Situations - Lung and other thoracic tumours
Curriculum in Translational Research in Breast Cancer